Dr. Barbara Paldus Redefines Skincare in TEDx Talk on the Skin-Gut-Brain Connection

San Jose, Calif. - May 13, 2025 - Dr. Barbara Paldus, a leading biotech innovator and founder of Codex Labs [http://codexlabscorp.com/], recently delivered a powerful TEDx Talk titled "Healthy Skin Starts From Within." Throughout her TEDx Talk, Dr. Paldus shares how being a mother of a child struggling with eczema led her to explore the skin-gut-brain biome and develop skincare products that target skin issues from within.

The Founder

Dr. Paldus holds over 50 patents, speaks five languages fluently, has a Ph.D. from Stanford University, and is a serial entrepreneur. She created Codex Labs alongside an innovative team of dermatologists and ethnobotanists to provide affordable, clinically proven skin-gut-brain solutions that support the microbiome and deliver healthy skin, without sacrificing sustainability.

The Mission

In her TEDx Talk, Dr. Paldus discusses how her son was exposed to a preservative in a skincare product, which caused a skin allergy called contact dermatitis. This later developed into eczema and led to an ADHD diagnosis.

"Children who have eczema are at much higher risk of developing ADHD," says Dr. Paldus. "The skin-gut microbiome is very real."

Dr. Paldus shares how she challenges the status quo of dermatology with plant-based biotechnology. She believes it is important to transform conventional medicine into a holistic, whole-body approach that considers the interconnectedness of skin, gut, and brain health.

"I firmly believe that skin-gut-brain-biome will represent and usher in a healthier future for the one billion people suffering from skin conditions like acne, eczema, psoriasis, and rosacea," says Dr. Paldus. "I also believe that in time we will prove that these integrative solutions are not only as effective as conventional medicine, but have no side effects."

Dr. Paldus's full TEDx Talk is now available to watch online at the following link: https://www.youtube.com/watch?v=rXNt_X5F67I.

To learn more about Dr. Paldus, her background in innovative skincare solutions, and Codex Labs' approach to clinically-proven results, visit codexlabscorp.com [http://codexlabscorp.com/].

About Dr. Barbara Paldus, Codex Labs:

Dr. Barbara Paldus is the founder and CEO of Codex Labs, a biotech company grounded in science, dedicated to supporting the microbiome and pioneering products with clinically proven, meaningful skincare benefits. Canadian-born of Czech parents and fluent in five languages with a Ph.D. from Stanford University (U.S.), Dr. Barbara Paldus holds over 50 US patents and is a serial entrepreneur, having started companies like Picarro (greenhouse gas detection for climate change) and Finesse Solutions (biotechnology equipment for vaccines like COVID-19, cancer therapeutics and cell therapy).

Codex Labs was conceived with dermatologists and ethnobotanists to provide affordable, clinically proven skin-gut-brain solutions that support the microbiome and deliver healthy skin, without sacrificing sustainability. Codex Labs understands you must treat skin from the inside out and achieves this through its plant-based biotech nutraceutical and OTC topical treatments for acne, eczema, rosacea, and psoriasis.

Media Contact
Company Name: Otter Public Relations
Contact Person: Anna Kate Womack
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=dr-barbara-paldus-redefines-skincare-in-tedx-talk-on-the-skingutbrain-connection]
Phone: 7032323140
City: ORLANDO
State: FL
Country: United States
Website: http://www.otterpr.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.